Dr. Jay R. Meyer, MD
Emergency Medicine (Emergency Medicine Physician)
1600 S 48th St, Er Dept
Lincoln, NE 68506
Who else practices at this address →
Lancaster County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Nebraska College of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 281
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: University of Nebraska College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Emergency Medicine Physician primary
NE license 23305
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Bryan Medical Center Lincoln, NE
- Beatrice Community Hospital & Health Center, Inc Beatrice, NE
Medical groups
- Nebraska Emergency Medicine PC (31 clinicians)
- Medelite Urgent Care LLC (9 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 281
- Services billed
- 622
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Emergency department visit with high level of medical decision making | 16 | 16 |
| Emergency department visit with moderate level of medical decision making | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Lincoln, NE | 34 |
| Prednisone Other prescribers in Lincoln, NE | 26 |
| Ondansetron Hcl Other prescribers in Lincoln, NE | 15 |
| Azithromycin Other prescribers in Lincoln, NE | 13 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Lincoln, NE | 11 |
| Cefdinir Other prescribers in Lincoln, NE | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $20.09 in total to this clinician.
| Medtronic, Inc. | $20.09 |
|---|
| Food and Beverage | $20.09 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 27 industry-funded studies in 2025, from 11 companies. The companies reported $3,221,075 in research payments for these studies, mostly to the institutions running them.
- Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
Valneva Austria GmbH · Completed · NCT06334393 - A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
ModernaTX, Inc. · Active, not recruiting · NCT06592794 - A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
ModernaTX, Inc. · Completed · NCT06602024 - Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older
Sanofi Pasteur Inc. · Active, not recruiting · NCT06686654 - A phase 1 double-blind, randomized, dose-finding clinical trial with an open-label run-in part to assess the safety and immunogenicity of an inactivated, adjuvanted whole zika virus vaccine candidate (VLA1601) in heal…
Valneva Austria GmbH - Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS
Csl Behring · Terminated · NCT06524739 - A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
ModernaTX, Inc. · Completed · NCT05815498 - Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
Seqirus USA Inc · Completed · NCT05875961 - A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age
ModernaTX, Inc. · Completed · NCT07117487 - A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
ModernaTX, Inc. · Active, not recruiting · NCT05164094
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.